World's largest vaccine manufacturer signs agreement with St. Jude

Parents around the world — and their children — can breathe a sigh of relief: St. Jude Children's Research Hospital has signed a licensing agreement to complete development and commercialization of an RSV vaccine. The agreement between the hospital and the Serum Institute of India gives the latter the exclusive right t o complete development of a St. Jude vaccine against respiratory syncytial virus (RSV) for use in South America, Africa and much of Asia. “RSV remains a serious threat to infants…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news